Advertisement
Research Article| Volume 65, ISSUE 11, P1451-1460, November 2012

Percutaneous sclerotherapy of vascular malformations in children using sodium tetradecyl sulphate: The Birmingham experience

  • Kenneth Kok
    Correspondence
    Corresponding author. Apartment 106, Newhampton Lofts, 99 Branston Street, Birmingham B18 6BG, United Kingdom. Tel.: +44 121 472 1311.
    Affiliations
    Department of Plastic and Reconstructive Surgery, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom

    Department of Radiology, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom
    Search for articles by this author
  • Ian McCafferty
    Affiliations
    Department of Plastic and Reconstructive Surgery, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom

    Department of Radiology, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom
    Search for articles by this author
  • Andrew Monaghan
    Affiliations
    Department of Maxillo-Facial Surgery, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham B15 2TH, West Midlands, United Kingdom
    Search for articles by this author
  • Hiroshi Nishikawa
    Affiliations
    Department of Plastic and Reconstructive Surgery, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom

    Department of Radiology, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, West Midlands, United Kingdom
    Search for articles by this author

      Summary

      Introduction and aims

      Sclerotherapy has become first line treatment for most venous malformations and some lymphatic malformations. We aimed to measure our sclerotherapy treatment success using 3% sodium tetradecyl sulphate (STD) and describe our experience.

      Materials and methods

      Retrospective five year review (Jan 04–09) of children with vascular malformations treated at our centre with 3% STD. Patients were classified using the Birmingham classification and treatment success was measured through case note review and pre- and post-treatment photographs.

      Findings and results

      Forty-three (84.3%) of the 51 patients with vascular malformations (VM) who underwent sclerotherapy derived a benefit. Twelve patients (23.5%) had an excellent result, 31 (60.8%) were improved whilst eight (15.7%) were unchanged. Using Fisher's exact test, there was a statistically significant difference in achieving complete resolution of superficial VMs compared to lesions involving the deeper layers of the head and neck. 17.6% of patients developed a complication with an overall complication rate of 12.2% per injection. There was one major complication with the remainder consisting of superficial skin necrosis that resolved conservatively.

      Conclusions

      Treatment with 3% STD sclerotherapy is effective in venous and some lymphatic vascular malformations. It should be considered an important treatment modality within a multi-disciplinary setting in these difficult problems.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mulliken J.B.
        • Glowacki J.
        Haemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.
        Plast Reconstr Surg. 1982; 69: 412-422
      1. Mulliken JB. Vascular anomalies. In: Thorne CH, editor. Grabb & Smith's plastic surgery. Chapter 22. 6th ed. New York: Lippincott Williams & Wilkins.

        • Jackson I.T.
        • Carreno R.
        • Potparic Z.
        • et al.
        Haemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment.
        Plast Reconstr Surg. 1993; 91: 1216-1230
        • Konez O.
        • Burrows P.E.
        Magnetic resonance imaging of vascular anomalies.
        Magn Reson Imaging Clin N Am. 2002; 10 (vii): 363-388
        • Puig S.
        • Casati B.
        • Staudenherz A.
        • et al.
        Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy.
        Eur J Radiol. 2005; 53: 35-45
        • Lee B.B.
        New approaches to the treatment of congenital vascular malformations (CMVs): a single centre experience.
        Eur J Vasc Endovasc Surg. 2005; 30: 184-197
        • Kane W.J.
        • Morris S.
        • Jackson I.T.
        • Woods J.E.
        Significant hemangiomas and vascular malformations of the head and neck: clinical management and treatment outcomes.
        Ann Plast Surg. 1995; 35: 133-143
        • Greene A.K.
        • Burrows P.E.
        • Smith L.
        • Mulliken J.B.
        Periorbital lymphatic malformation: clinical course and management in 42 patients.
        Plast Recontr Surg. 2005; 115: 22-30
        • Mendonca D.A.
        • McCafferty I.
        • Nishikawa H.
        • Lester R.
        Venous malformations of the limbs: the Birmingham experience, comparisons and classification in children.
        J Plast Reconstr Aesthet Surg. 2010 Mar; 63: 383-389
        • Choi Y.H.
        • Han M.H.
        • O-Ki K.
        • et al.
        Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
        J Vasc Interv Radiol. 2002; 13: 475-482
        • Tolins S.H.
        Treatment of varicose veins. An update.
        Am J Surg. 1983 Feb; 145: 248-252
        • Siniluoto T.M.
        • Svendsen P.A.
        • Wikholm G.A.
        • et al.
        Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol).
        Scand J Plast Reconstr Surg Hand Surg. 1997; 31: 145-150
        • Orsini C.
        • Brotto M.
        Immediate pathologic effects on the vein wall of foam sclerotherapy.
        Dermatol Surg. 2007 Oct; 33: 1250-1254
        • Tan K.T.
        • Kirby J.
        • Rajan D.K.
        • et al.
        Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous malformations: a single centre experience.
        J Vasc Interv Radiol. 2007; 18: 343-351
        • Jackson I.T.
        • Carreno R.
        • Potparic Z.
        • Hussain K.
        Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment.
        Plast Reconstr Surg. 1993 Jun; 91: 1216-1230
        • Garzon M.C.
        • Huang J.T.
        • Enjolras O.
        • et al.
        Vascular malformations: part 1.
        J Am Acad Dermatol. 2007; 56: 353-370
        • Rautio R.
        • Saarinen J.
        • Laranne J.
        • Salenius J.P.
        • Keski-Nisula L.
        Endovascular treatment of venous malformations in extremities: results of sclerotherapy and the quality of life after treatment.
        Acta Radiol. 2004; 45: 397-403
        • Goyal M.
        • Causer P.A.
        • Armstrong D.
        Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification.
        Radiology. 2002; 223: 639-644
        • Berenguer B.
        • Burrows P.E.
        • Zurakowski D.
        • Mulliken J.B.
        Sclerotherapy of craniofacial venous malformations: complications and results.
        Plast Reconstr Surg. 1999 Jul; 104: 1-11
        • Jin Y.
        • Lin X.
        • Chen H.
        • et al.
        Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome.
        J Oral Maxillofac Surg. 2009 Nov; 67: 2388-2396